{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:09:02Z","timestamp":1779304142677,"version":"3.51.4"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.1001\/jamaneurol.2022.1824","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T15:01:33Z","timestamp":1657551693000},"page":"949","source":"Crossref","is-referenced-by-count":9,"title":["Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors"],"prefix":"10.1001","volume":"79","author":[{"given":"Valentina","family":"Damato","sequence":"first","affiliation":[{"name":"Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom"},{"name":"Department of Neurosciences, Drugs and Child Health, University of Florence, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Berretta","sequence":"additional","affiliation":[{"name":"Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Translational Neuroimmunology Group, Kids Neuroscience Centre, Children\u2019s Hospital at Westmead, Westmead, Australia"},{"name":"Department of Neurology, Concord Hospital, Sydney, Australia"},{"name":"Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Michael","sequence":"additional","affiliation":[{"name":"Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Coupe","sequence":"additional","affiliation":[{"name":"Department of Oncology, Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Payne","sequence":"additional","affiliation":[{"name":"Department of Oncology, Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarosh R.","family":"Irani","sequence":"additional","affiliation":[{"name":"Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"nld220003r1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.v87.5","article-title":"Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum.","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann Neurol"},{"issue":"5","key":"nld220003r2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acn3.2018.5.issue-5","article-title":"Seronegative antibody-mediated neurology after immune checkpoint inhibitors.","volume":"5","author":"Wilson","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"nld220003r3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/jnnp-2020-323055","article-title":"Central nervous system complications associated with immune checkpoint inhibitors.","volume":"91","author":"Vogrig","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"nld220003r4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain"},{"issue":"7","key":"nld220003r5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/jamaoncol.2019.0402","article-title":"Association of checkpoint inhibitor-induced toxic effects with shared cancer and tissue antigens in non\u2013small cell lung cancer.","volume":"5","author":"Berner","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"nld220003r6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002890","article-title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.","volume":"9","author":"Guidon","year":"2021","journal-title":"J Immunother Cancer"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2793875\/jamaneurology_damato_2022_ld_220003_1662471579.94521.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T15:05:28Z","timestamp":1662995128000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2793875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.1824","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}